Search
Research
Progress toward a global Group A streptococcal vaccineThe desire for an effective vaccine arises from the large burden of disease caused by the bacterium, particularly rheumatic fever and rheumatic heart disease.
Research
Group A streptococcal vaccines: Paving a path for accelerated developmentVaccine prevention of GAS infections and their immunological complications has been a goal of researchers for decades.
Research
Maternal Alcohol Use and Sudden Infant Death Syndrome and Infant Mortality Excluding SIDSThe highest risk of SIDS occurred when a maternal alcohol diagnosis was recorded during pregnancy or within 1 year postpregnancy.
Research
"Through the Kids... We Connected With Our Community": Children as Catalysts of Social CapitalThis article investigates whether having dependent children living at home play a role in forging adult connections, community involvement, and social...
Research
Descriptive epidemiology of cleft lip and cleft palate in Western AustraliaThese data provide a picture of the prevalence of OFCs in WA since 1980, and provide a useful reference for OFC data in Australia and internationally.
Research
Early Onset Binge Eating and Purging Eating Disorders: Course and Outcome in a Population-Based Study of AdolescentsPurging at age 17 and externalising behaviour problems at age 14 were the strongest predictors of eating disorder persistence to age 20.
Research
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisMultiple sclerosis is a common disease of the central nervous system in which the interplay between inflammatory and neurodegenerative processes typically...
Research
Just what the doctor ordered: moving forward with electronic health recordsTo provide dietitians with information on the proposed introduction of electronic medical records in Australia and New Zealand and discuss potential benefits...
Research
Predominance of nontypeable haemophilus influenzae in children with otitis mediaIn Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.
Research
Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell toleranceConcerns about the risk of inducing immune deviation-associated "neonatal tolerance" as described in mice have restricted the widespread adoption...